Chahar Sanjay, Gandhi Vishal, Yu Shiyan, Desai Kinjal, Cowper-Sal-lari Richard, Kim Yona, Perekatt Ansu O, Kumar Namit, Thackray Joshua K, Musolf Anthony, Kumar Nikhil, Hoffman A, Londono Douglas, Vazquez Berta N, Serrano Lourdes, Shin Hyunjin, Lupien Mathieu, Gao Nan, Verzi Michael P
Human Genetics Institute of New Jersey and Department of Genetics, Rutgers, the State University of New Jersey, Piscataway, New Jersey, USA.
Department of Biological Sciences, Rutgers, the State University of New Jersey, Newark, New Jersey, USA.
Mol Cell Biol. 2014 Sep;34(17):3291-304. doi: 10.1128/MCB.00349-14. Epub 2014 Jun 30.
Transcriptional regulatory mechanisms likely contribute to the etiology of inflammatory bowel disease (IBD), as genetic variants associated with the disease are disproportionately found at regulatory elements. However, the transcription factors regulating colonic inflammation are unclear. To identify these transcription factors, we mapped epigenomic changes in the colonic epithelium upon inflammation. Epigenetic marks at transcriptional regulatory elements responded dynamically to inflammation and indicated a shift in epithelial transcriptional factor networks. Active enhancer chromatin structure at regulatory regions bound by the transcription factor hepatocyte nuclear factor 4α (HNF4A) was reduced during colitis. In agreement, upon an inflammatory stimulus, HNF4A was downregulated and showed a reduced ability to bind chromatin. Genetic variants that confer a predisposition to IBD map to HNF4A binding sites in the human colon cell line CaCo2, suggesting impaired HNF4A binding could underlie genetic susceptibility to IBD. Despite reduced HNF4A binding during inflammation, a temporal knockout model revealed HNF4A still actively protects against inflammatory phenotypes and promotes immune regulatory gene expression in the inflamed colonic epithelium. These findings highlight the potential for HNF4A agonists as IBD therapeutics.
转录调控机制可能在炎症性肠病(IBD)的病因学中起作用,因为与该疾病相关的基因变异在调控元件中不成比例地被发现。然而,调节结肠炎症的转录因子尚不清楚。为了鉴定这些转录因子,我们绘制了炎症时结肠上皮细胞的表观基因组变化。转录调控元件处的表观遗传标记对炎症有动态反应,并表明上皮转录因子网络发生了转变。在结肠炎期间,转录因子肝细胞核因子4α(HNF4A)结合的调控区域的活性增强子染色质结构减少。与此一致的是,在炎症刺激下,HNF4A表达下调,且结合染色质的能力降低。在人结肠癌细胞系CaCo2中,赋予IBD易感性的基因变异定位于HNF4A结合位点,这表明HNF4A结合受损可能是IBD遗传易感性的基础。尽管在炎症期间HNF4A结合减少,但一个时间性敲除模型显示HNF4A仍能积极预防炎症表型,并促进炎症结肠上皮中的免疫调节基因表达。这些发现凸显了HNF4A激动剂作为IBD治疗药物的潜力。